ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach

January 17, 2024

https://www.globenewswire.com/news-release/2024/01/17/2810709/0/en/ELEVAI-LABS-Inc-Reports-Strong-Preliminary-Unaudited-Financial-Performance-for-Fiscal-Year-2023-Highlighting-Significant-Revenue-Growth-and-Expanding-Global-Reach.html

NEWPORT BEACH, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) — ELEVAI LABS, INC., (NASDAQ:ELAB) a medical aesthetic company specializing in physician-dispensed skincare, today announced certain preliminary, unaudited management-prepared financial results for the fiscal year ended December 31, 2023. These results are based on the most current information available to management, are unaudited, and subject to the completion of the Company’s year-end financial reporting processes, reviews, audit, and potential adjustments that might result.

Read more at globenewswire.com

Related news for (ELAB)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.